| abstract |
The present invention relates to novel aminopyrrolidines of formula (I), pharmaceutically acceptable salts thereof, metabolites thereof, isomers thereof, stereoisomers thereof or prodrugs thereof (variable elements are as defined herein). As defined in the book). Since the compounds of formula (I) are useful as chemokine receptor antagonists, they are useful in the treatment of certain conditions and diseases, in particular inflammatory conditions and diseases and proliferative disorders and conditions such as cancer it is conceivable that. |